Mazindol Extended Release (NLS)

马吲哚缓释剂(NLS)

Report date: 2023/04/13 11:09:54

Base Information

Drug NameMazindol Extended Release (NLS)
Drug Alias NameMazindol controlled release(NLS)马吲哚控释剂(NLS)NolazolQuilienceNLS-1 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitorsDopamine reuptake inhibitors
TargetsDopamine transporterNorepinephrine transporter
Therapy Area/IndicationsNarcolepsyDisorders of Excessive Somnolence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNls Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNls PharmaInsud Pharma
Inactive CompaniesN/A
Active IndicationsNarcolepsyDisorders of Excessive Somnolence
Inactive IndicationsN/A

Other Information

ATC CodeA08AA05
Related LinksWikipediaDrugBankKEGG